Cargando…
Remdesivir Use Compared With Supportive Care in Hospitalized Patients With Severe COVID-19: A Single-Center Experience
BACKGROUND: The US Food and Drug Administration issued an Emergency Use Authorization for remdesivir use in patients with severe COVID-19. METHODS: We utilized data from 2 quaternary acute care hospitals. The outcomes of interest were the impact of remdesivir on in-hospital death by day 28 and time...
Autores principales: | Kalligeros, Markos, Tashima, Karen T, Mylona, Evangelia K, Rybak, Natasha, Flanigan, Timothy P, Farmakiotis, Dimitrios, Beckwith, Curt G, Sanchez, Martha, Neill, Marguerite, Johnson, Jennie E, Garland, Joseph M, Aung, Su, Byrd, Katrina M, O’Brien, Thomas, Pandita, Aakriti, Aridi, Jad, Macias Gil, Raul, Larkin, Jerome, Shehadeh, Fadi, Mylonakis, Eleftherios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7454852/ https://www.ncbi.nlm.nih.gov/pubmed/33117850 http://dx.doi.org/10.1093/ofid/ofaa319 |
Ejemplares similares
-
Characteristics and outcomes of Hispanic/Latinx patients with coronavirus disease 19 (COVID-19) requiring hospitalization in Rhode Island: a retrospective cohort study
por: Macias Gil, Raul, et al.
Publicado: (2021) -
Incidence and potential risk factors for remdesivir-associated bradycardia in hospitalized patients with COVID-19: A retrospective cohort study
por: Alsowaida, Yazed Saleh, et al.
Publicado: (2023) -
Hydroxychloroquine use in hospitalised patients with COVID-19: An observational matched cohort study
por: Kalligeros, Markos, et al.
Publicado: (2020) -
How Comorbidities Affect Hospitalization from Influenza in the Pediatric Population
por: Mylonakis, Sophia C., et al.
Publicado: (2022) -
The association of obesity with health insurance coverage and demographic characteristics: a statewide cross-sectional study
por: Mylona, Evangelia K., et al.
Publicado: (2020)